Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: grannylu who wrote (795)	2/4/1999 3:04:00 AM
From: Bajasurfer	Respond to of 1754

As I understand it the SNRS machine treats only farsightedness. The VISX S2 can do farsightedn ess, nearsightedness and astigmatism. I hope SNRS does well.... I expect this to have no effect on VISX at all... Robert

To: grannylu who wrote (795)	2/6/1999 7:54:00 AM
From: emil	Respond to of 1754

"I'd like some opinions on this" I would suggest buying SNRS! Seriously, I was told the market potential for SNRS is 10x's that of VISX's, which is a big reason that I started looking into the co.. I will look forward to wall streets reaction to what many will be calling, the next VISX. I don't think it will cause Visx to go out of business just yet <G>, but it may be prudent to sell a portion of shares and diversify into SNRS. The growth VISX has experienced may not be what it will do from here on out. I dont have first hand knowledge, since I only follow VISX from a far, but I do know the projections for SNRS are very exciting and that is where I have invested my money. Good luck with your decision.